All sponsors

Shandong Suncadia Medicine Co., Ltd.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS25
PHASE 3 / 2-39
RECRUITING20
READOUTS ≤12 MONTHS8
READOUT SLIPPED >6 MO36%

Delay Index: of 11 active trials registered more than a year ago, 4 have moved their primary completion (readout) date by more than 6 months since first registration (median +0.0 months). See all sponsors →

Open Shandong Suncadia Medicine Co., Ltd. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
HRS-1893
NCT06516068
P2Active, not recruitingObstructive Hypertrophic Cardiomyopathy422024-11-18
HRS-8080; Dalpiciclib Isethionate Tablets
NCT06167694
P1/2RecruitingUnresectable or Metastatic Breast Cancer1462026-06 (+7 mo)
HRS-1301
NCT07229937
P2RecruitingHyperlipidemia1892026-08
HRS-1893 Tablets
NCT07021976
P3Active, not recruitingObstructive Hypertrophic Cardiomyopathy2282026-09
HRS-2129 Tablet
NCT07706777
P2RecruitingAcute Gouty Arthritis902026-10
HRS-2189
NCT06679036
P1/2RecruitingAdvanced Unresectable or Metastatic Breast Cancer3002026-10-30
HRS-1780 Tablets
NCT07470983
P2Active, not recruitingPrimary Aldosteronism612026-11
HRS-7535 tablet
NCT06820099
P2RecruitingAdults With Heart Failure, Mild Decrease in Ejection Fraction/Preserved Ejection Fraction, and Obesity2252026-12
HRS-7085
NCT07229950
P2RecruitingAdult Patients With Moderately to Severely Active Ulcerative Colitis482026-12 (+9 mo)
HRS-7058 + SHR-1316
NCT06915142
P2RecruitingAdvanced Malignant Tumour3002026-12
HRS-5346
NCT07767513
P2RecruitingLipoprotein Disorder602027-02
HRS-1893 Tablet
NCT07269717
P2RecruitingHeart Failure With Preserved Ejection Fraction482027-03
HRS-7058
NCT07032077
P2RecruitingSolid Tumors1002027-06 (+12 mo)
HRS-8080 Tablet
NCT07024173
P3RecruitingLocally Advanced Breast Cancer; Metastatic Breast Cancer2402027-08 (+8 mo)
HRS-6719
NCT06922357
P1/2RecruitingAdvanced/Metastatic Solid Tumors1202027-12
HRS-7535
NCT07528027
P3RecruitingHypertension With Overweight or Obesity6482027-12
HRS-1893 Tablet
NCT07021963
P2RecruitingHypertrophic Cardiomyopathy3002027-12
HRS-7058
NCT07601048
P3Not yet recruitingKRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment4502028-05
HRS-6208 Capsule
NCT07389733
P1/2RecruitingAdvanced Unresectable or Metastatic Breast Cancer of Adults1802028-12
HRS-8080 Tablet ; Dalpiciclib Isethionate
NCT07354022
P3RecruitingLocally Advanced or Metastatic Breast Cancer9122028-12
HRS-7058
NCT07589569
P2RecruitingPancreatic Cancer922028-12
HRS-1780 tablet
NCT07708441
P2/3RecruitingUncontrolled or Resistant Hypertension9142029-04
HRS-1780 tablets
NCT07419828
P3RecruitingChronic Kidney Disease53862030-04
HRS-8080 Tablets
NCT07349069
P3RecruitingBreast Cancer55002030-12
RENEW-CKD
NCT07625774
P3Not yet recruitingChronic Kidney Disease36902031-05